Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
3,332
Views
2
CrossRef citations to date
0
Altmetric
Articles

Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis

Taro Edahiroa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Takakazu Kawasea Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Hisao Nagoshia Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Keita Fujinoa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Kayo Toishigawaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanORCID Iconhttps://orcid.org/0000-0003-0781-5141View further author information
ORCID Icon,
Takahiko Miyamaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Tatsuji Minoa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Tetsumi Yoshidaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Takehiko Moriokaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Yuji Hirataa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Mitsunori Nomab Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, JapanView further author information
,
Teruhisa Fujiib Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, JapanView further author information
,
Masatoshi Nishizawac Next Generation Development of Genome and Cellular Therapy Program, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanView further author information
,
Noriyasu Fukushimaa Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanORCID Iconhttps://orcid.org/0000-0002-1391-8043View further author information
ORCID Icon &
Tatsuo Ichinohea Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan;c Next Generation Development of Genome and Cellular Therapy Program, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, JapanCorrespondence[email protected]
View further author information
 show all
Pages 186-198 | Published online: 17 Feb 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.